DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-2,708 Cr | ₹-2,195 Cr | ₹75 Cr | ₹-83 Cr | ₹-685 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2023 | ₹-2,708 Cr |
Mar2022 | ₹-2,195 Cr |
Mar2021 | ₹75 Cr |
Mar2020 | ₹-83 Cr |
Mar2019 | ₹-685 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-2,708 Cr | Negative | |
Mar2022 | ₹-2,195 Cr | Negative | |
Mar2021 | ₹75 Cr | Positive | |
Mar2020 | ₹-83 Cr | Negative | |
Mar2019 | ₹-685 Cr | - |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹100,611.2 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹358,305.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹109,709.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,073.3 Cr | -3.7% | -1.4% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,383.3 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
MANKIND PHARMA | ₹86,841.6 Cr | -6.6% | -6.6% | NA | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.9% |
5% |
19.2% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses